Reactions of [Pt(PEt(3))(3)] (1) with the silanes HSiPh(3), HSiPh(2)Me and HSi(OEt)(3) led to the products of oxidative addition, cis-[Pt(H)(SiPh(3))(PEt(3))(2)] (2), cis-[Pt(H)(SiPh(2)Me)(PEt(3))(2)] (3), cis-[Pt(H){Si(OEt)(3)}(PEt(3))(2)] (cis-4) and trans-[Pt(H){Si(OEt)(3)}(PEt(3))(2)] (trans-4). The complexes cis-4 and trans-4 can also be generated by hydrogenolysis of (EtO)(3)SiSi(OEt)(3) in the presence of 1. Furthermore, the silyl compounds cis-4 and trans-4 react with B(C(6)F(5))(3) and CH(3)CN by hydride abstraction to give the cationic silyl complex trans-[Pt{Si(OEt)(3)}(NCCH(3))(PEt(3))(2)][HB(C(6)F(5))(3)] (8). In addition, the reactivity of the complexes cis-4, trans-4 and 8 towards alkenes and CO was studied using NMR experiments.
The activation of Ph(2)HSiSiHPh(2) and Me(3)SiSiMe(3) at [Pt(PEt(3))(3)] (1) yielded the products of oxidative addition. The formation of [Pt(SiHPh(2))(2)(PEt(3))(2)] (2) as a mixture of the cis and trans isomers appears to proceed quantitatively, whereas a conversion to give cis-[Pt(SiMe(3))(2)(PEt(3))(2)] (3) was not complete. Treatment of 1 with one equivalent of H(2)SiPh(2) led to cis-and trans-[Pt(H)(SiHPh(2))(PEt(3))(2)] (cis-4, trans-4) together with the dinuclear complex [(Et(3)P)(2)(H)Pt(μ-SiPh(2))(μ-η(2)-HSiPh(2))Pt(PEt(3))] (5). In contrast, HSiMe(3) reacts with [Pt(PEt(3))(3)] to yield cis-[Pt(H)(SiMe(3))(PEt(3))(2)] (7) exclusively. Catalytic reactions of dihydrogen with the disilanes Ph(2)HSiSiHPh(2) or Me(3)SiSiMe(3) in the presence of catalytic amounts of [Pt(PEt(3))(3)] (1) led to the products of hydrogenolysis, H(2)SiPh(2) and HSiMe(3). The conversion of Me(3)SiSiMe(3) is much slower and needs higher temperature to proceed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.